Svenson S - Search Results

1

Dendrimers in biomedical applications--reflections on the field.

Svenson S, Tomalia DA. Svenson S, et al. Adv Drug Deliv Rev. 2005 Dec 14;57(15):2106-29. doi: 10.1016/j.addr.2005.09.018. Epub 2005 Nov 21. Adv Drug Deliv Rev. 2005. PMID: 16305813 Review.

2

Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

Tomalia DA, Reyna LA, Svenson S. Tomalia DA, et al. Among authors: svenson s. Biochem Soc Trans. 2007 Feb;35(Pt 1):61-7. doi: 10.1042/BST0350061. Biochem Soc Trans. 2007. PMID: 17233602

3

Dendrimers for enhanced drug solubilization.

Svenson S, Chauhan AS. Svenson S, et al. Nanomedicine (Lond). 2008 Oct;3(5):679-702. doi: 10.2217/17435889.3.5.679. Nanomedicine (Lond). 2008. PMID: 18817470 Review.

4

Dendrimers as versatile platform in drug delivery applications.

Svenson S. Svenson S. Eur J Pharm Biopharm. 2009 Mar;71(3):445-62. doi: 10.1016/j.ejpb.2008.09.023. Epub 2008 Oct 17. Eur J Pharm Biopharm. 2009. PMID: 18976707 Review.

5

The dendrimer paradox--high medical expectations but poor clinical translation.

Svenson S. Svenson S. Chem Soc Rev. 2015 Jun 21;44(12):4131-44. doi: 10.1039/c5cs00288e. Chem Soc Rev. 2015. PMID: 25971933 Review.

6

Theranostics: are we there yet?

Svenson S. Svenson S. Mol Pharm. 2013 Mar 4;10(3):848-56. doi: 10.1021/mp300644n. Epub 2013 Feb 4. Mol Pharm. 2013. PMID: 23379301 Review.

7

What nanomedicine in the clinic right now really forms nanoparticles?

Svenson S. Svenson S. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Mar-Apr;6(2):125-35. doi: 10.1002/wnan.1257. Epub 2014 Jan 10. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014. PMID: 24415653

8

Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.

Svenson S, Wolfgang M, Hwang J, Ryan J, Eliasof S. Svenson S, et al. J Control Release. 2011 Jul 15;153(1):49-55. doi: 10.1016/j.jconrel.2011.03.007. Epub 2011 Mar 23. J Control Release. 2011. PMID: 21406204 Free article.

9

Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.

Svenson S, Case RI, Cole RO, Hwang J, Kabir SR, Lazarus D, Lim Soo P, Ng PS, Peters C, Shum P, Sweryda-Krawiec B, Tripathi S, van der Poll D, Eliasof S. Svenson S, et al. Mol Pharm. 2016 Mar 7;13(3):737-47. doi: 10.1021/acs.molpharmaceut.5b00608. Epub 2016 Feb 2. Mol Pharm. 2016. PMID: 26835715

10

Discovery of a Novel Cabazitaxel Nanoparticle-Drug Conjugate (CRLX522) with Improved Pharmacokinetic Properties and Anticancer Effects Using a β-Cyclodextrin-PEG Copolymer Based Delivery Platform.

Metcalf CA 3rd, Svenson S, Hwang J, Tripathi S, Gangal G, Kabir S, Lazarus D, Cole R, Sweryda-Krawiec B, Shum P, Brown D, Case RI, van der Poll D, Rohde E, Harlfinger S, Teng CH, Eliasof S. Metcalf CA 3rd, et al. Among authors: svenson s. J Med Chem. 2019 Nov 14;62(21):9541-9559. doi: 10.1021/acs.jmedchem.9b00892. Epub 2019 Oct 24. J Med Chem. 2019. PMID: 31593466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page